CBMOS Selects INTEGRA Media Preparator
Researchers at the Centro Biología Molecular Severo Ochoa (CBMSO) in Madrid, Spain have demonstrated how the MEDIACLAVE Media Preparator and the DOSE IT Peristaltic Pump from INTEGRA can significantly enhance the efficiency and reproducibility of fly food preparation.
Drosophila melanogaster, the common fruit fly, is a commonly used model research organism in genetics, physiology and evolutionary development biology. Successful experiments using Drosophila typically depend on optimal husbandry and on providing good fly food quality. In some Drosophila labs, hundreds of vials are filled each day with fly food.
Mercedes Dávila, Head of Media Preparation Services at CBMOS commented: “Using a basic media cooking pot approach we could not accurately control the temperature of our ‘fly food’ during preparation and had to stir the mixture manually using a ladle. Because of the high viscosity of the fly food our technicians found filling all the vials a time-consuming and tedious process and often the food quality vial to vial was not consistent.” She added: “Our subsequent purchase of a stirrer kettle helped to improve the fly food mixture quality. Preparing the food, however, was still much too slow because it took several hours to cool the mixture to dispensing temperature.”
CBMSO’s investment in an INTEGRA MEDIACLAVE 30 Media Preparator and a DOSE IT peristaltic pump finally was the solution to this problem. Reflecting on the advantages that CBMSO had gained from the INTEGRA system, Mercedes Dávila said: “Our MEDIACLAVE 30 gives us the possibility to prepare 30 L of fly food in only 95 min. The integrated cooling system makes the process much faster than previous solutions.” She continued: “We can now keep the fly food mixture at the desired dispensing temperature. This allows us to dispense the food directly from the cuvette into the vials, without risking contamination or premature solidification inside the dispensing tubing”. Concluding, Mercedes Dávila said: “The electronic or paper process documentation from the INTEGRA system has enabled us to have standardized methods and fully traceable quality”.
To watch the MEDIACLAVE and DOSE IT being used for preparing fly food please visit www.youtube.com/watch?
For further information on the MEDIACLAVE 30 media preparation system and DOSE-IT peristaltic pump please visit www.integra-biosciences.com/
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases.
-
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Dr Reddy's to launch generic semaglutide in India
Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a... -
News Frontier Biotech and GSK Forge RNA Therapy Partnership
Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...